Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors
US8076356B2 · kind B2 · utility
0Cited by
10References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2009 |
| Grant date | Dec 13, 2011 |
| Priority date | — |
| Expiry date | Feb 16, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula (I), or a pharmaceutical acceptable salt and/or solvate (including hydrate) thereof;and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.